Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00235209 · ClinicalTrials.gov registry record · Phase 4
A Study to Evaluate the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Venous Leg Ulcers
A Phase 4 study of Leg Ulcer, sponsored by Ethicon.
- Completed
- Registry status
- Phase 4
- Development phase
- 48
- Enrollment target
- 3
- Study locations
NCT00235209: Completed Phase 4 study of Leg Ulcer, sponsored by Ethicon.
NCT00235209 is a Phase 4 study of Leg Ulcer that has completed, run by Ethicon. The registered enrollment target is 48 participants, below the 37,715-participant average among 8 other Leg Ulcer trials with a reported enrollment target (100% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00235209, a Phase 4 study of Leg Ulcer, has completed, sponsored by Ethicon.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 48 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a randomized (1:1), prospective, open label, multicenter, comparative study to be examine the effectiveness of Collagen-ORC Antimicrobial matrix, a new wound dressing, on venous leg ulcers.
Conditions Studied
Interventions
- DEVICE Collagen ORC Antimicrobial Matrix (CAM)
Study Locations (3)
Florida
- Wound Care Center - Fort Lauderdale
- Foot and Ankle Institute of South Florida - South Miami
Pennsylvania
- Penn North Centers for Advanced Wound Care - Warren
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2004-11 |
| Est. Completion | 2005-12 |
| Phase | Phase 4 |
What the finished NCT00235209 record still lists
NCT00235209 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 37,715-participant average among 8 other Leg Ulcer trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Leg Ulcer appearing as the primary indexed condition, and to 1 intervention - of which Collagen ORC Antimicrobial Matrix (CAM) is the first listed.
NCT00235209 reports a single indexed study location in Florida, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00235209 about?
NCT00235209 is a clinical study titled "A Study to Evaluate the Clinical Effectiveness of a Collagen-ORC Antimicrobial Matrix in Venous Leg Ulcers". This is a randomized (1:1), prospective, open label, multicenter, comparative study to be examine the effectiveness of Collagen-ORC Antimicrobial matrix, a new wound dressing, on venous leg ulcers.
What is the current status of trial NCT00235209?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 48 participants. The study started on 2004-11. Estimated completion is 2005-12.
What conditions does trial NCT00235209 study?
This clinical trial studies the following conditions: Leg Ulcer.
What interventions are being tested in trial NCT00235209?
The interventions under investigation include: Collagen ORC Antimicrobial Matrix (CAM) (DEVICE).
Who is sponsoring clinical trial NCT00235209?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00235209 being conducted?
This trial has 3 study locations across Florida, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leg Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00235209's enrollment target sits among peer trials
48 7th of 8 higher than 1 of 8 other Leg Ulcer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Leg Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
RECRUITING · Phase 4
-
Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
RECRUITING · Phase 4
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
Modified Multi-Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of DFU and VLUs
RECRUITING · NA
-
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
RECRUITING · NA
-
Evaluating the Safety and Efficacy of Fractionated Carbon Dioxide Therapy in Postoperative Lower Extremity Wound Healing
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia